Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-25-335481

Chief Legal Officer sold 11,276 shares at $13.15 ($148,244)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sullivan Mark Chief Legal Officer 2025-12-26 Sale 10b5-1 −11,276 $13.15 $148,244 282,576 D: show line 1 in the form
Open-market sales · 11,276 sh · avg $13.15 · $148,244
Loading xslF345X05/ownership.xml…